Jason Hoitt - Insider Trading & Ownership

Location
C/O Dova Pharmaceuticals, Inc., 240 Leigh Farm Road, Suite 245, Durham, NC
Summary
The estimated net worth of Jason Hoitt is at least $16.1K dollars as of June 23, 2025. Jason Hoitt is the Chief Patient Officer of Stoke Therapeutics, Inc. and owns shares of Stoke Therapeutics, Inc. (STOK) stock worth about $16.1K.
Signature
/s/ Jonathan Allan, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Jason Hoitt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
STOK Stoke Therapeutics, Inc. Chief Patient Officer $16.1K Jun 18, 2025
PRVB Provention Bio, Inc. Chief Commercial Officer Apr 27, 2023

Insider Transactions Reported by Jason Hoitt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.